Natural product mitigation of ferroptosis in platinum-based chemotherapy toxicity: targeting the underpinning oxidative signaling pathways
Journal of Pharmacy and Pharmacology · 06.01.2025 · 77 (1) · 1-17
DOI: 10.1093/jpp/rgae132 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.11.2024. Verfasst von Ademola C Famurewa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Basic Medical Sciences, College of Medical Sciences, Alex Ekwueme Federal University, Ikwo 482103, Ebo…. Hauptthemen laut MEDLINE: Ferroptosis, Antineoplastic Agents, Cisplatin, Signal Transduction. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Indian Council of Medical Research, Postdoctoral Research and Training at Liverpool John Moores University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
Platinum-based anticancer chemotherapy (PAC) represents a cornerstone in cancer treatment, retaining its status as the gold standard therapy. However, PAC’s efficacy is countered by significant toxicities, such as nephrotoxicity, ototoxicity, and neurotoxicity. Recent studies have linked these toxicities to ferroptosis, characterized by iron accumulation, reactive oxygen species generation, and lipid peroxidation. This review explores the mechanisms underlying PAC-induced toxicities, focusing on the involvement of ferroptosis with three major PAC drugs—cisplatin, carboplatin, and oxaliplatin. Further, we provide a comprehensive analysis of the natural product mitigation of PAC-induced ferroptotic toxicity. Key findings The mechanistic role of ferroptosis in cisplatin- and oxaliplatin-induced toxicities has been investigated, while studies on carboplatin-induced ferroptotic toxicities are lacking. Natural compounds targeting molecular pathways of ferroptosis have been explored to mitigate PAC-induced ferroptotic toxicity.
Conclusion
While ferroptosis in cisplatin- and oxaliplatin-induced toxicities has been investigated, there remains a notable dearth of studies examining its involvement in carboplatin-induced toxicities. Hence, further exploration is warranted to define the role of ferroptosis in carboplatin-induced toxicities, and its further mitigation. Moreover, in-depth mechanistic evaluation is necessary to establish natural products evaluated against PAC-induced ferroptosis, as PAC adjuvants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry, Faculty of Basic Medical Sciences, College of Medical Sciences, Alex Ekwueme Federal University, Ikwo 482103, Ebonyi State, Nigeria.
- Centre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, United Kingdom.
- Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal 576104, India.
ORCID-Profile: Nupura Manish Prabhune, Sudharshan Prabhu
Förderung
- Indian Council of Medical Research
- Postdoctoral Research and Training at Liverpool John Moores University
Zitieren
APA
Famurewa, A. C., Prabhune, N. M., & Prabhu, S. (2025). Natural product mitigation of ferroptosis in platinum-based chemotherapy toxicity: targeting the underpinning oxidative signaling pathways. Journal of Pharmacy and Pharmacology, 77(1), 1-17. https://doi.org/10.1093/jpp/rgae132
Vancouver
Famurewa AC, Prabhune NM, Prabhu S. Natural product mitigation of ferroptosis in platinum-based chemotherapy toxicity: targeting the underpinning oxidative signaling pathways. Journal of Pharmacy and Pharmacology. 2025;77(1):1-17. doi:10.1093/jpp/rgae132
BibTeX
@article{Famurewa2025,
author = {Famurewa, Ademola C and Prabhune, Nupura Manish and Prabhu, Sudharshan},
title = {Natural product mitigation of ferroptosis in platinum-based chemotherapy toxicity: targeting the underpinning oxidative signaling pathways},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
volume = {77},
number = {1},
pages = {1--17},
doi = {10.1093/jpp/rgae132}
}
EUVIMED